Statistics for KemPharm (id:8245 ZVRA)

Valuation metrics

Market cap

450.93M

Enterprise value

481.67M

Trailing P/E (ttm)

-7.37

Forward P/E

-21.97

PEG ratio

-21.97

Price/Sales (ttm)

19.04

Price/Book (mrq)

11.09

Enterprise Value/Revenue

20.33

Enterprise Value/EBITDA

-6.80

Overview

Shares outstanding

52.62M

Float

49.29M

Shares short

5.00M

% Held by insiders

0.07%

% Held by institutions

0.33%

Average volume (10 days)

617.36K

Average volume (90 days)

Price summary

52-Week low

4.20

52-Week high

9.64

52-Week change

48.88%

Beta

1.93

50-Day moving average

7.91

200-Day moving average

6.22

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

December 28th, 2020

Ex-dividend date

Last split factor

2:1

Last split date

December 28th, 2020

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-282.01%

Operating margin

-534.84%

Operational effectiveness

Return on assets

-37.41%

Return on equity

-132.32%

Income statement

Revenue (ttm)

0.60

Revenue per share (ttm)

0.60

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-70,829,000.00

Net income to common (ttm)

-66,806,000.00

Diluted EPS (ttm)

-1.71

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

49.26M

Total cash per share (mrq)

0.94

Total debt (mrq)

59.47M

Total Debt/Equity (mrq)

183.10

Current ratio (mrq)

200.00%

Book value per share (mrq)

0.77

Cash flow

Cash flow statement

-56,060,000.00

Levered free cash flow (LFCF)

-21,000,624.00